Patent details

Basic Information

Publication number:

EP1299102

PCT Application Number:

PCT/FR/2001/001729

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019406875

PCT Publication Number:

WO/2001/093802

First applicant's nationality:

Translation Language:

EPO Publication Language:

French

English Title of Invention:

USE OF RILUZOLE OR ITS SALTS FOR PREVENTING AND TREATING ADRENOLEUKODYSTROPHY

French Title of Invention:

UTILISATION DU RILUZOLE OU SES SELS POUR LA PREVENTION ET LE TRAITEMENT DE L'ADRENOLEUCODYSTROPHIE

German Title of Invention:

VERWENDUNG DES RILUZOLS ODER DESSEN SALZEN ZUR PHOPHYLAXE UND BEHANDLUNG DER ADRENOLEUKODYSTROPHIE

SPC Number:

Dates

Filing date:

05/06/2001

Grant date:

19/04/2006

EP Publication Date:

19/04/2006

PCT Publication Date:

13/12/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

09/04/2003

EP B1 Publication Date:

19/04/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/06/2014

Expiration date:

05/06/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/06/2001

 

 

Name:

Aventis Pharma S.A.

Address:

20, avenue Raymond Aron, 92160 Antony, France (FR)

Name:

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Address:

101, RUE DE TOLBIAC, 75654 PARIS CÉDEX 13, France (FR)

Inventor

1

Name:

AUBOURG Patrick

Address:

France (FR)

2

Name:

STUTZMANN Jean-Marie

Address:

France (FR)

3

Name:

DIB Michel

Address:

France (FR)

Priority

Priority Number:

0007162

Priority Date:

05/06/2000

Priority Country:

France (FR)

Classification

Main IPC Class:

A61K 31/425;

Filing date	Document type	Number of pages